Optimizing Titer And Use Of A Specific Enzyme For Generating A Fully Processed Antibody
Summary: In Biologics, the market climate requires increasing speed to move the product to the next phase of development. Even before a product is proven effective in clinical trials, several decisions must be made. Read the article featuring Steven Hager, Ph.D., biomanufacturing expert on the new trends, latest strategies in biomanufacturing and integrated approach on improving and de-risking lead selection.